More Memphasys Ltd news
Memphasys LtdASX: MEM

Felix Clinical Registration Study completed, expanding mkt

Dec 17, 2024 at 9:34 PM EST · Issued by Memphasys Ltd

Filed with ASX · Dec 17, 2024 at 9:34 PM EST

On 6ix: 6ix.com/news/felix-clinical-registration-study-completed-expanding-mkt

Memphasys Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

Memphasys Ltd on 6ix

Earlier from Memphasys

  • Letter of Intent with Heranova for Felix System DistributionDec 11, 2024
  • Order for Felix System to Evaluate Suitability in UAEDec 4, 2024
  • RoXsta System's Potential in Cattle Breeding being ExploredDec 4, 2024
  • Felix Clinical Trial Reaches 95% CompletionNov 17, 2024
  • RoXsta System Secures Provisional Patent ApprovalNov 14, 2024

Later from Memphasys

  • Bovine Study commences to assess RoXsta antioxidant systemDec 19, 2024
  • Heranova Felix System Utilisation Testing commences in ChinaJan 5, 2025
  • Publication Highlights Diagnostic Potential of RoXsta TMJan 15, 2025
  • Felix Clinical Trial complete, Data Lock expected in 2 weeksFeb 10, 2025
  • Leading Brazilian Andrology Clinic to test Felix SystemFeb 16, 2025
All Memphasys news releases↗

Follow Memphasys into a list and get an email when it puts out news.

Follow Memphasys
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer